Cellectis S.A.
CLLS
$3.59
$0.092.57%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -67.59M | -35.35M | -59.00M | -60.53M | -36.76M |
| Total Depreciation and Amortization | 18.84M | 20.03M | 19.74M | 19.45M | 19.09M |
| Total Amortization of Deferred Charges | 1.23M | 758.00K | 758.00K | 758.00K | 758.00K |
| Total Other Non-Cash Items | 49.72M | 20.44M | 27.09M | 18.13M | -13.76M |
| Change in Net Operating Assets | -41.59M | -34.96M | -21.94M | 51.34M | 53.67M |
| Cash from Operations | -39.40M | -29.09M | -33.35M | 29.14M | 22.99M |
| Capital Expenditure | -2.36M | -2.43M | -2.03M | -2.76M | -2.58M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -27.12M | -66.17M | -40.80M | -93.77M | -100.23M |
| Cash from Investing | -29.48M | -68.60M | -42.82M | -96.53M | -102.81M |
| Total Debt Issued | -- | 6.88M | 6.99M | 6.95M | 23.20M |
| Total Debt Repaid | -16.19M | -15.86M | -15.84M | -15.87M | -16.06M |
| Issuance of Common Stock | 44.00K | -- | 0.00 | 82.82M | 82.82M |
| Repurchase of Common Stock | -- | -1.00K | -1.00K | -1.00K | -1.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -612.00K | -718.00K | -803.00K | -772.00K | -847.00K |
| Cash from Financing | -16.76M | -9.70M | -9.65M | 73.13M | 89.11M |
| Foreign Exchange rate Adjustments | 3.93M | 533.00K | -3.41M | -1.07M | -2.75M |
| Miscellaneous Cash Flow Adjustments | 0.00 | 3.00K | 0.00 | 1.00K | 1.00K |
| Net Change in Cash | -81.72M | -106.84M | -89.23M | 4.67M | 6.54M |